home / stock / snce / snce news

SNCE News and Press, Science 37 Holdings Inc. From 03/07/22

Stock Information
Company Name: Science 37 Holdings Inc.
Stock Symbol: SNCE
Market: NASDAQ
Website: science37.com
Menu
SNCE SNCE Quote SNCE Short SNCE News SNCE Articles SNCE Message Board
Get SNCE Alerts

News, Short Squeeze, Breakout and More Instantly...
SNCE - SUNW, CEI and HNRG among mid-day movers

Gainers: Houston American Energy HUSA +157%. Imperial Petroleum IMPP +95%. Indonesia Energy Corporation INDO +74%. Camber Energy (NYSE:CEI) +49%. Nine Energy Service NINE +42%. Sunworks (NASDAQ:SUNW) +31%. Bed Bath & Beyond BBBY +28%. Eqonex EQOS +28%. Marine...
SNCE - New Science 37® CNS Survey Confirms Growing Trend in Clinical Trials Landscape

RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today published new CNS (Central Nervous System) therapeutic data validating the growing trend toward decentralization as two-thirds ...

SNCE - Science 37®'s Operating System Receives ISO Certification for Information Security Management

RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced its Operating System has earned ISO 27001 certification for cybersecurity management as well as the ISO 27701:2019 priv...

SNCE - Science 37® to Present at the Cowen 42nd Annual Health Care Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Cowen 42 nd Annual Health Care Conference. Science 37 ...
SNCE - Science 37®'s Community Provider Network Grows Sixfold, Reaching Nearly 28 Million Patients

RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ bolstered its centralized network of community providers by six times during the past year, contracting with more than 800 healthcare o...

SNCE - Science 37® and physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

RESEARCH TRIANGLE PARK, N.C. and CHICAGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use remote biosens...

SNCE - Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials(TM) and Accelerate Study Timelines

RESEARCH TRIANGLE PARK, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO) and Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating Sys...
SNCE - Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development

LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Science 37, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System, today announced it has added capability to meet regulatory requirements and deploy its full-stack, end-to-end technology platform into China and Russia—further e...

SNCE - Science 37® Reveals a Pivotal Shift in the Clinical Trials Landscape

LOS ANGELES, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37”), pioneer of decentralization and Operating System for today’s more agile clinical trials™, has published new data suggesting that the clinical research industry...

SNCE - Science 37 EPS misses by $1.30, beats on revenue

Science 37 (NASDAQ:SNCE): Q3 GAAP EPS of -$3.23 misses by $1.30. Revenue of $14.24M (+116.4% Y/Y) beats by $1.15M. Press Release For further details see: Science 37 EPS misses by $1.30, beats on revenue

Previous 10 Next 10